<DOC>
	<DOCNO>NCT00463775</DOCNO>
	<brief_summary>The objective present study evaluate efficacy topiramate ( 250mg/day ) versus placebo decrease aggression reduce alcohol consumption patient borderline personality disorder ( BPD ) alcohol dependence ( AD ) .</brief_summary>
	<brief_title>Topiramate Treatment Patients With Borderline Personality Disorder Alcohol Dependence</brief_title>
	<detailed_description>Background : Borderline personality disorder ( BPD ) affect 2 % American adult population . It serious psychiatric disorder place heavy demand mental health resource . Behavior dysregulation ( impulsivity , self-injurious act , drink aggressive behavior ) consider one main feature BPD associate significant clinical morbidity . Alcohol abuse common among patient BPD , co-morbid rate alcoholism BPD patient estimate 30 % . It hypothesize alcohol misuse may manifestation BPD 's behavioral dysregulation . Also , BPD alcohol dependence ( AD ) share common underlie neurobiology . The co-occurrence disorder associate increased rate alcohol relapse , impulsive behavior , great resistance treatment , suicidal behavior . Effective treatment patient BPD AD would result markedly reduce health care cost substantial reduction human distress suffering . Despite dramatic advance treatment BPD , date , single medication type medication uniquely identify effective treating BPD . Studies treat patient co-morbid BPD AD expressly lack . Research Design Methodology : This 8-week double-blind outpatient clinical trial oral topiramate ( 250mg ) v placebo individual BPD AD . The study conduct West Haven , CT VA. Thirty men woman current diagnosis BPD AD enrol . The State-Trait Anger Expression Inventory ( STAEI ) use assess 5 aspect aggression : state anger , trait anger , anger express inwardly , anger express outwardly , anger control treatment ( week 0-8 ) . The Timeline Follow-Back ( TLFB ) method use document degree daily alcohol consumption treatment ( 90 day treatment , week 0 - 8 ) . Emergent side effect assess use modify version Systematic Assessment Treatment Emergent Events ( SAFTEE ) .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Personality Disorders</mesh_term>
	<mesh_term>Borderline Personality Disorder</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<criteria>Diagnosis AD Diagnosis BPD Serious unstable medical condition Opiate dependence Major Axis I disorder ( bipolar disorder , schizophrenia ) Taking mood stabilizer antipsychotic medication LFT abnormality exceed 3 time normal value</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Treatment</keyword>
	<keyword>Topiramate</keyword>
	<keyword>Alcohol Dependence</keyword>
	<keyword>Borderline Personality Disorder</keyword>
</DOC>